Greatview Aseptic Packaging Company Limited
GRVWF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2021 FY | 3.46B | 697.66M | 362.32M | 285.07M | 0.21 |
| 2022 FY | 3.94B | 587.96M | 227.48M | 182.40M | 0.14 |
| 2023 FY | 3.82B | 681.11M | 319.64M | 244.21M | 0.18 |
| 2025 FY | 1.81B | 274.07M | 45.79M | 51.39M | 0.04 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2021 FY | 3.66B | 1.24B | 425.24M | 311.22M | 2.42B |
| 2022 FY | 4.28B | 1.66B | 607.44M | 240.54M | 2.62B |
| 2023 FY | 4.03B | 1.13B | 866.66M | 167.70M | 2.90B |
| 2025 FY | 3.58B | 675.90M | 634.52M | 101.20M | 2.90B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2021 FY | 133.83M | -87.96M | 45.87M | -288.60M | -152.00M |
| 2022 FY | 345.19M | -87.64M | 257.55M | — | 182.20M |
| 2023 FY | 442.25M | -104.36M | 337.89M | — | 259.22M |
| 2025 FY | 251.13M | -47.50M | 203.63M | -275.39M | -211.50M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2021 FY | 2.86B | 2.75B | — | — | — |
| 2022 FY | 1.73B | 1.36B | — | — | — |
| 2023 FY | 2.34B | 1.64B | — | — | — |
| 2025 FY | 2.54B | 2.01B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 Q4 | 1.93B | 384.09M | 194.35M | 144.39M | 0.11 |
| 2024 Q2 | 1.63B | 330.06M | 145.77M | 114.82M | 0.08 |
| 2025 Q2 | 986.51M | 157.65M | 67.28M | 81.15M | 0.06 |
| 2025 Q4 | 836.16M | 118.46M | -21.30M | -29.56M | -0.02 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 Q4 | 4.03B | 1.13B | 866.66M | 167.70M | 2.90B |
| 2024 Q2 | 3.97B | 826.62M | 780.29M | 55.68M | 3.10B |
| 2025 Q2 | 3.81B | 596.49M | 568.59M | 1.73M | 3.21B |
| 2025 Q4 | 3.58B | 675.90M | 634.52M | 101.20M | 2.90B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 Q4 | 445.57M | -87.58M | 357.99M | — | 373.59M |
| 2024 Q2 | 108.85M | -74.14M | 34.70M | — | 780.29M |
| 2025 Q2 | 7.37M | -14.88M | -7.51M | — | -155.63M |
| 2025 Q4 | 246.24M | -33.30M | 212.94M | -277.99M | -59.59M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 Q4 | 2.34B | 1.64B | — | — | — |
| 2024 Q2 | 3.06B | 2.34B | — | — | — |
| 2025 Q2 | 2.85B | 2.29B | — | — | — |
| 2025 Q4 | 2.54B | 2.01B | — | — | — |